About Sanoptis
Sanoptis is a company based in Schwyz (Switzerland) founded in 2018 was acquired by GBL in April 2022. Sanoptis has raised $269.73 million across 1 funding round from investors including The Carlyle Group and GBL. Sanoptis offers products and services including Eye Care Services and Partnership Programs.
- Headquarter Schwyz, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sanoptis
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$269.73 M (USD)
in 1 rounds
-
Latest Funding Round
$269.73 M (USD), Private Equity Round
Mar 26, 2025
-
Investors
The Carlyle Group
& 1 more
-
Employee Count
Not available
-
Acquired by
GBL
(Apr 20, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sanoptis
Sanoptis offers a comprehensive portfolio of products and services, including Eye Care Services and Partnership Programs.
High-standard ophthalmic care is delivered through innovative diagnostics and therapies in a network of clinics.
Support for ophthalmologists is facilitated through investments, knowledge transfer, and operational optimizations.
People of Sanoptis
Unlock access to complete
Funding Insights of Sanoptis
Sanoptis has successfully raised a total of $269.73M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $269.73 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sanoptis
Sanoptis has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include The Carlyle Group and GBL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
GBL is established as an investment holding company in Europe.
|
Locked | Locked | Locked |
Investor details for Sanoptis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sanoptis
Investment portfolio details for Sanoptis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sanoptis
Detailed financials for Sanoptis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sanoptis Comparisons
Peer comparison for Sanoptis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sanoptis
Detailed competitors of Sanoptis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sanoptis
Complete news archive for Sanoptis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanoptis
Sanoptis was founded in 2018 and raised its 1st funding round 7 years after it was founded.
Sanoptis is headquartered in Schwyz, Switzerland. It is registered at Schwyz, Schwyz, Switzerland.
Volker Wendel is the current CEO of Sanoptis.
Sanoptis is a funded company, having raised a total of $269.73M across 1 funding round to date.
Network of eye clinics and practices offering ophthalmological services. It provides a platform for modern eye clinics and practices. The company facilitates collaborations, investments, and training for improved patient care. It fosters knowledge sharing among medical professionals. The company supports recruitment and development of medical staff. It advises clinics and practices on optimizing operations, personnel, finance, and marketing. The company invests in equipment and facilities to ensure treatment in a comfortable environment.
Sanoptis offers Eye Care Services and Partnership Programs.
Sanoptis has 2 investors. Key investors include The Carlyle Group, and GBL.